GSA Capital Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-14,383
| Closed | -$235K | – | 1946 |
|
|
2021
Q4 | $235K | Buy |
+14,383
| New | +$235K | 0.03% | 1112 |
|
|
2020
Q4 | – | Sell |
-6,848
| Closed | -$83K | – | 1702 |
|
|
2020
Q3 | $83K | Buy |
6,848
+501
| +8% | +$6.07K | 0.01% | 1150 |
|
|
2020
Q2 | $73K | Buy |
+6,347
| New | +$73K | 0.04% | 518 |
|
|
2020
Q1 | – | Sell |
-11,769
| Closed | -$69K | – | 1681 |
|
|
2019
Q4 | $69K | Buy |
+11,769
| New | +$69K | 0.01% | 1358 |
|
|
2016
Q4 | – | Sell |
-3,800
| Closed | -$236K | – | 2017 |
|
|
2016
Q3 | $236K | Buy |
+3,800
| New | +$236K | 0.01% | 1512 |
|
|
2016
Q2 | – | Sell |
-3,960
| Closed | -$254K | – | 1965 |
|
|
2016
Q1 | $254K | Buy |
3,960
+760
| +24% | +$48.7K | 0.02% | 1387 |
|
|
2015
Q4 | $450K | Buy |
3,200
+740
| +30% | +$104K | 0.02% | 1225 |
|
|
2015
Q3 | $238K | Buy |
+2,460
| New | +$238K | 0.01% | 1494 |
|